Report
Syndax Pharmaceuticals stock plunges after failed drug trial
Barron's reports the failed trial dealt a blow to the company's growth plans.
TLDR
Barron's reports that Syndax Pharmaceuticals' stock plunged and a failed drug trial dealt a blow to the company's growth plans.
Combined views
3.5K
1 Source, first seen ago
likes